In addition, it has been demonstrated that liver-specific knockdown of nuclear receptor subfamily 2, group F, member 6 (NR2F6) alleviated obesity-associated hepatosteatosis and MCD diet-induced NASH through downregulating CD36 expression in mouse models [76]. This evidence concerns the gene NR2F6 and obesity disorder.